SEC Form 4/A · accession 0001209191-15-006344
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeffrey W Sherman
Officer — EVP and Chief Medical Officer
Period of report
Jan 2, 2014
Accepted (ET)
Jan 26, 2015 · 8:54 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 2, 2014 | M | 11,250 | — | A | 102,596 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 2, 2014 | M | 11,250 | D | — | — | Common Stock | 45,000 | 33,750 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
- F2On January 2, 2013, the reporting person was granted 45,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
Remarks
This amendment is being made to report the vesting of a portion of a restricted stock award, which was inadvertently omitted from the original Form 4. The securities reflected in this report represent securities of Horizon Pharma, Inc., a Delaware corporation. Such securities subsequently converted to securities of Horizon Pharma plc.